NCT06550531

Impact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP)

Impact of Human Papillomavirus Carriage on IVF/ICSI Results at Brest University Hospital

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 618 (estimated)
• Sponsor: University Hospital, Brest · Academic / Other
• Sex: Female
• Age: 25 Years – 38 Years
• Healthy volunteers: Not accepted

Summary

The prevalence of the papilloma virus in the general population is 12%. This virus is known to impair male fertility but its impact on female infertility remains uncertain. This is a public health problem since there is a vaccination protocol. Demonstrating the impact of the human papillomavirus on fertility would be an argument in favor of vaccination.

Detailed description

This is a single-center prospective study in the assisted reproduction center of Brest University Hospital. All new patients coming to consult will be offered participation in the study. The HPV test will be updated if it is older than 12 months. We will analyze stimulation results and pregnancy outcomes according to HPV status. Inclusions will take place over 3 years

Conditions

• Human Papilloma Virus
• Infertility, Female

Timeline

• Start date: 2022-02-04
• Primary completion: 2026-02-04
• Completion: 2026-02-04
• First posted: 2024-08-13
• Last updated: 2024-08-13

Locations

1 site across 1 country: France